GB0507811A
GB0507811D0
(en)
|
2005-04-18 |
2005-04-18 |
Formulation
|
NZ551990A
NZ551990A
(en)
|
2004-06-04 |
2005-06-06 |
Liquid depot formulations
|
SG2011047453A
SG173326A1
(en)
|
2004-06-04 |
2005-06-06 |
Liquid depot formulations
|
EP05749850A
EP1768650B1
(en)
|
2004-06-04 |
2005-06-06 |
Liquid depot formulations
|
CA2569513A
CA2569513C
(en)
|
2004-06-04 |
2005-06-06 |
Preformulation for liquid crystalline phase structure
|
MXPA06014095A
MXPA06014095A
(es)
|
2004-06-04 |
2005-06-06 |
Formulaciones de deposito de lipidos.
|
US11/628,007
US8236292B2
(en)
|
2004-06-04 |
2005-06-06 |
Liquid depot formulations
|
CN200580021940.8A
CN101014319B
(zh)
|
2004-06-04 |
2005-06-06 |
液体贮库制剂
|
AU2005249274A
AU2005249274B2
(en)
|
2004-06-04 |
2005-06-06 |
Liquid depot formulations
|
CN2010102495161A
CN102008728B
(zh)
|
2004-06-04 |
2005-06-06 |
液体贮库制剂
|
ES05749850T
ES2309766T3
(es)
|
2004-06-04 |
2005-06-06 |
Formulaciones liquidas de liberacion lenta.
|
AT05749850T
ATE401054T1
(de)
|
2004-06-04 |
2005-06-06 |
Flüssige depotformulierungen
|
PL05749850T
PL1768650T3
(pl)
|
2004-06-04 |
2005-06-06 |
Ciekłe formulacje depot
|
DK05749850T
DK1768650T3
(da)
|
2004-06-04 |
2005-06-06 |
Flydende depotformuleringer
|
JP2007514136A
JP5127449B2
(ja)
|
2004-06-04 |
2005-06-06 |
流体デポ製剤
|
KR1020077000258A
KR101225257B1
(ko)
|
2004-06-04 |
2005-06-06 |
유동성 데포 제제
|
RU2006146009/15A
RU2390331C2
(ru)
|
2004-06-04 |
2005-06-06 |
Жидкие депо-препараты
|
PCT/GB2005/002217
WO2005117830A1
(en)
|
2004-06-04 |
2005-06-06 |
Liquid depot formulations
|
BRPI0511807A
BRPI0511807C8
(pt)
|
2004-06-04 |
2005-06-06 |
pré-formulação, processo de formação de uma pré-formulação e uso da mesma
|
DE602005008247T
DE602005008247D1
(de)
|
2004-06-04 |
2005-06-06 |
Flüssige depotformulierungen
|
EP09014796A
EP2206495B1
(en)
|
2005-01-14 |
2005-12-09 |
Topical bioadhesive formulations
|
PL05818606T
PL1845942T3
(pl)
|
2005-01-14 |
2005-12-09 |
Preparaty analogu GnRH
|
CA2594710A
CA2594710C
(en)
|
2005-01-14 |
2005-12-09 |
Topical bioadhesive formulations
|
AU2005324794A
AU2005324794C1
(en)
|
2003-11-07 |
2005-12-09 |
Somatostatin analogue formulations
|
ES05818366T
ES2363419T3
(es)
|
2005-01-14 |
2005-12-09 |
Formulaciones de análogos de somatostatina.
|
KR1020077018617A
KR100983746B1
(ko)
|
2005-01-14 |
2005-12-09 |
소마토스타틴 유사 제형
|
CA2594718A
CA2594718C
(en)
|
2005-01-14 |
2005-12-09 |
Gnrh analogue formulations
|
JP2007550827A
JP5107725B2
(ja)
|
2005-01-14 |
2005-12-09 |
GnRH類似体製剤
|
DK05818606.5T
DK1845942T3
(da)
|
2005-01-14 |
2005-12-09 |
GNRH-analogformuleringer
|
EP05818366A
EP1843746B1
(en)
|
2005-01-14 |
2005-12-09 |
Somatostatin analogue formulations
|
AT05818337T
ATE462409T1
(de)
|
2005-01-14 |
2005-12-09 |
Topische bioadhäsive formulierungen
|
PCT/GB2005/004752
WO2006075125A1
(en)
|
2005-01-14 |
2005-12-09 |
GnRH ANALOGUE FORMULATIONS
|
SI200531846T
SI1845942T1
(sl)
|
2005-01-14 |
2005-12-09 |
Gnrh analogne formulacije
|
PCT/GB2005/004746
WO2006075123A1
(en)
|
2005-01-14 |
2005-12-09 |
Topical bioadhesive formulations
|
DE602005020359T
DE602005020359D1
(de)
|
2005-01-14 |
2005-12-09 |
Topische bioadhäsive formulierungen
|
PCT/GB2005/004748
WO2006075124A1
(en)
|
2005-01-14 |
2005-12-09 |
Somatostatin analogue formulations
|
US11/795,242
US8920782B2
(en)
|
2005-01-14 |
2005-12-09 |
Topical bioadhesive formulations
|
ES05818606.5T
ES2458992T3
(es)
|
2005-01-14 |
2005-12-09 |
Formulaciones de análogos de GnRH
|
US11/795,249
US8871712B2
(en)
|
2005-01-14 |
2005-12-09 |
Somatostatin analogue formulations
|
JP2007550826A
JP5171262B2
(ja)
|
2005-01-14 |
2005-12-09 |
ソマトスタチン類似体製剤
|
ES05818337T
ES2343641T3
(es)
|
2005-01-14 |
2005-12-09 |
Formulaciones bioadhesivas topicas.
|
PL05818337T
PL1848403T3
(pl)
|
2005-01-14 |
2005-12-09 |
Preparaty bioadhezyjne o działaniu miejscowym
|
EP05818606.5A
EP1845942B1
(en)
|
2005-01-14 |
2005-12-09 |
Gnrh analogue formulations
|
EP05818337A
EP1848403B8
(en)
|
2005-01-14 |
2005-12-09 |
Topical bioadhesive formulations
|
AT05818366T
ATE501710T1
(de)
|
2005-01-14 |
2005-12-09 |
Somatostatin-analog-formulierungen
|
DE602005026998T
DE602005026998D1
(de)
|
2005-01-14 |
2005-12-09 |
Somatostatin-analog-formulierungen
|
CA2594711A
CA2594711C
(en)
|
2005-01-14 |
2005-12-09 |
Somatostatin analogue formulations
|
JP2007550825A
JP5144277B2
(ja)
|
2005-01-14 |
2005-12-09 |
局所用生体付着性製剤
|
PL05818366T
PL1843746T3
(pl)
|
2005-01-14 |
2005-12-09 |
Formulacje analogów somatostatyny
|
US11/795,250
US9757461B2
(en)
|
2005-01-14 |
2005-12-09 |
GnRH analogue formulations
|
ES09014796T
ES2400034T3
(es)
|
2005-01-14 |
2005-12-09 |
Formulaciones bioadhesivas tópicas
|
PL09014796T
PL2206495T3
(pl)
|
2005-01-14 |
2005-12-09 |
Bioadhezyjne formulacje do stosowania miejscowego
|
IL179815A
IL179815A
(en)
|
2004-06-04 |
2006-12-04 |
Liquids containing low-viscosity non-liquid crystals, their compositions and uses
|
US11/798,495
US8236755B2
(en)
|
2004-06-04 |
2007-05-14 |
Opioid depot formulations
|
AU2010202794A
AU2010202794B2
(en)
|
2004-06-04 |
2010-07-01 |
Liquid depot formulations
|
US13/537,096
US8545832B2
(en)
|
2004-06-04 |
2012-06-29 |
Lipid depot formulations
|
JP2012156518A
JP5731446B2
(ja)
|
2005-01-14 |
2012-07-12 |
局所用生体付着性製剤
|
US13/558,463
US20130190341A1
(en)
|
2004-06-04 |
2012-07-26 |
High bioavailability opioid formulations
|
US14/017,823
US20140193347A1
(en)
|
2004-06-04 |
2013-09-04 |
Lipid depot formulations
|
US14/138,704
US9649382B2
(en)
|
2005-01-14 |
2013-12-23 |
Topical bioadhesive formulations
|
US14/143,665
US20140219935A1
(en)
|
2005-01-14 |
2013-12-30 |
Topical bioadhesive formulations
|
US14/486,035
US20150064118A1
(en)
|
2004-06-04 |
2014-09-15 |
Lipid depot formulations
|
US14/551,761
US9968680B2
(en)
|
2005-01-14 |
2014-11-24 |
Topical bioadhesive formulations
|
US15/653,993
US20180078647A1
(en)
|
2005-01-14 |
2017-07-19 |
Gnrh analogue formulations
|
US16/030,697
US20180311163A1
(en)
|
2004-06-04 |
2018-07-09 |
Lipid depot formulations
|
US16/947,934
US20210128473A1
(en)
|
2004-06-04 |
2020-08-25 |
Lipid depot formulations
|
US17/731,534
US20230027339A1
(en)
|
2004-06-04 |
2022-04-28 |
Lipid depot formulations
|